Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations

  • Insights from ASCO GU: An Exclusive Interview with UBC’s Marie-Pier St-Laurent | Oncology Frontier

    Welcome to a special feature by Oncology Frontier, where we bridge the gap between continents in the realm of medical innovation. Today, we’re honored to host Marie-Pier St-Laurent from the University of British Columbia. As part of our exclusive Specialist Interview series, Marie-Pier will be sharing valuable insights from her recent abstract presented at ASCO…

    2024.01.31

  • The U.S. Experience in HCV Screening, Linkage, and Treatment

    2024.01.31

  • Pinnacle Conversation | Advancements in the Diagnosis and Treatment of Metabolism-Related Fatty Liver Disease: Discussing New Developments, Sharing Experiences from Singapore and the United States, and Addressing Global Progress

    2024.01.31

  • Interview with AASLD President: A Resurgence of Vitality in the Field of Liver Disease, Highlights Galore at 2023 Annual Meeting

    2024.01.31

  • Four New Insights into the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

    2024.01.31

  • Progress in the Treatment of Intermediate and Advanced HCC, Highlighting the Value of Systemic Therapy

    2024.01.31

  • The main mechanisms and development prospects of HCC combination therapy

    2024.01.31

  • Clinical management, scientific research priorities and future action plan of MASLD

    2024.01.31
«previous next»
Recent Posts
  • Professor Yanhong Deng: Precision and Accessibility Go Hand in Hand—China-Developed Panitumumab N01 Opens a New Era of Fully Human Anti-EGFR Antibodies in mCRC
  • CSCO 2026 Global Perspectives | Professor William Gradishar: From Dual HER2 Blockade to the ADC Era—The Future and Transformation of HER2-Positive Breast Cancer Treatment
  • CSCO 2026 | Professor Binghao Li: Vebreltinib Plus Immunotherapy Explores a New Treatment Strategy for Advanced Clear Cell Sarcoma, with Potential Association Between c-MET Expression and Clinical Benefit
  • CSCO Global Perspectives | Professor Yi-Long Wu in Conversation with Professor Everett Vokes: Advances in MET-Amplified NSCLC—From Resistance Mechanism to Actionable Oncogenic Driver
  • CSCO 2026 | Celebrating Excellence in Oncology: Five Major Award Categories Announced at the CSCO Plenary Session
Recent Comments
    Archives
    • October 2026
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top